ZKIN vs HLIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

ZKIN

39.1
AI Score
VS
HLIO Wins

HLIO

45.8
AI Score

Investment Advisor Scores

ZKIN

39score
Recommendation
AVOID NEW MONEY

HLIO

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZKIN HLIO Winner
Forward P/E 0 11.7371 Tie
PEG Ratio 0 1.0321 Tie
Revenue Growth -43.5% 9.1% HLIO
Earnings Growth -97.7% 94.1% HLIO
Tradestie Score 39.1/100 45.8/100 HLIO
Profit Margin -28.0% 8.0% HLIO
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD HLIO

Relative Price Performance (Last 90 Days)

ZKIN 1M: +45.8% · 3M: +12.2% HLIO 1M: -2.3% · 3M: -17.5%

Current Technical Phase

ZKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.7 · Price: $1.56

HLIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $67.72

Fundamentals Snapshot

Metric ZKIN HLIO
Market Cap — —
Forward P/E 0.0 18.9
Trailing P/E — 31.6
Revenue (TTM) — —
Revenue Growth -0.4% 0.1%
Gross Margin 0.1% 0.3%
Operating Margin -8.0% 0.1%
EPS -1.44 2.14
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, HLIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.